Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Erigeron breviscapus is a traditional Chinese medicinal herb that has gained scientific interest for its potential neuroprotective effects. The primary active compounds, such as scutellarin, have been the subject of numerous studies. Preclinical research has demonstrated that extracts from Erigeron breviscapus can improve cerebral blood flow, inhibit platelet aggregation, and reduce oxidative stress, all of which are relevant to supporting brain health. Animal studies and some small-scale clinical trials suggest benefits in improving cognitive function and aiding in the recovery from ischemic stroke and vascular dementia. For example, several randomized controlled trials in China have reported that Erigeron breviscapus injection, used as an adjunct therapy, improved neurological deficits after stroke when compared to conventional treatment alone. However, while the results are promising, most human data come from studies with limited sample sizes, lack of blinding, or methodological weaknesses, and the studies are largely confined to East Asian populations. The evidence base does not yet meet the highest standards of clinical validation, but there is enough scientific research—especially from in vitro and animal models, as well as preliminary human studies—to justify a moderate evidence rating for supporting the brain body system, particularly in the context of cerebrovascular health. More large-scale, rigorously designed clinical trials are needed to confirm these findings and establish standardized dosing and safety profiles.

More about Erigeron breviscapus
More about Brain

Other ingredients that support Brain

Other body systems supported by Erigeron breviscapus

Products containing Erigeron breviscapus